PRTA
ProthenaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
2
U.S. public peers
Grade Position
Above peers
vs peer average
PRTA vs peer average
74/100
PRTA vs. peer average (C vs. D)
Grade spread
D 1 · F 1
Graded peers loaded
Coverage
2 graded
100% of tracked
Peer overview
ANVS is the first available peer comparator.
Late-stage neurodegenerative biotech focused on Alzheimer's and Parkinson's disease, providing a closer disease-area comparator than generic small-cap biotech names even though its modality differs.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PRTA
Prothena
ANVS
Annovis Bio
Grade
C
F
Momentum
29
13
Value
41
41
Sentiment
81
0
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs ANVS
PRTA / ANVS
Grade Position
Above peers
PRTA vs. peer average (C vs. D)
74/100
Momentum
29
PRTAValue
41
PRTASentiment
81
PRTARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
ANVS is the first peer returned for this comparison set.